Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
77,152,541
-
Share change
-
+4,667,951
-
Total reported value
-
$2,997,578,965
-
Put/Call ratio
-
263%
-
Price per share
-
$38.85
-
Number of holders
-
192
-
Value change
-
+$216,890,926
-
Number of buys
-
121
-
Number of sells
-
62
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2018
As of 30 Jun 2018 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 77,152,541 shares of stock of the company.
Largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FIL Ltd, and ArrowMark Colorado Holdings LLC.
This table shows 192 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.